Last reviewed · How we verify
NCT07284693
Clinical Study Evaluating the Efficacy of Phenolic Complex k110-42 Therapy on Cognitive Functions of Children With Down Syndrome
Phase 3 trial testing Phenolic complex k110-42 in Cognitive Functions in 108 participants. Not yet recruiting.
1 July 2026
Quick facts
| Lead sponsor | Mansoura University |
|---|---|
| Phase | Phase 3 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 108 |
| Start date | 1 January 2026 |
| Primary completion | 1 July 2026 |
| Estimated completion | 1 December 2026 |
Drugs / interventions tested
- Phenolic complex k110-42 — full drug profile →
- Neumentix — full drug profile →
Conditions studied
- Cognitive Functions — all drugs for Cognitive Functions →
Sponsor
Mansoura University
Who can join
Adults 4 to 8, any sex, with Cognitive Functions. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Cognitive functions
Time frame: At baseline before any intervention, at 3 month ,at 6 month
Cognitive assessment will be assessed using Conners' Kiddie Continuous Performance Test (K-CPT). -
Cognitive assessment will be assessed using the Wechsler Intelligence Scale for Children-Fourth Edition.
Time frame: At baseline before any intervention , at 3 month , at 6 month
Sponsor's own description
The goal of this study is to evaluate the efficacy of phenolic complex k110-42 on cognitive function of children with Down syndrome
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07284693
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cognitive Functions
Currently open trials in the same condition.
- NCT07372066 — Cognitive Stimulation Therapy Group for Residential Home Residents With Dementia and Mild Cognitive Impairment · NA · recruiting
- NCT07019324 — BDNF Levels in Cancer Patients Receiving Chemotherapy · active not recruiting
- NCT07364318 — Cognitive Function in Obstructive Sleep Apnea · recruiting
- NCT03812913 — Neuropsychological Assessment of Children and Adolescents With Turner Syndrome · recruiting
Other Mansoura University trials
Trials by the same sponsor.
- NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
- NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
- NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
- NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
- NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07284693 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mansoura University
- Last refreshed: 14 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07284693.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing